drugset / Trial / NCT00414102

Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

NCT00414102

Phase 4 Completed 552 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the subjective treatment effects of ramelteon, once daily (QD), on sleep using a post sleep questionnaire-interactive voice response system in adults with chronic insomnia.

Timeline

Start
2006-10
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg Oral

Indications